Relevance: Obesity is one of the most significant modern public health problems. The increasing prevalence of obesity in young women, particularly abdominal obesity, is accompanied by an increase in metabolic disorders such as latent diabetes mellitus, dyslipidemia, and hypertension, which significantly increases the risk of developing cardiovascular disease.
Study objective. To assess the prevalence and nature of metabolic disorders in young women with abdominal and exogenous-constitutional obesity.
Materials and methods: The study was conducted in a family clinic among women aged 18 to 44 years. A total of 204 women were examined. The subjects were divided into two groups: 44 women with abdominal obesity (waist circumference ≥88 cm) without a diagnosis of diabetes mellitus and 160 women with exogenous-constitutional obesity, divided into groups based on blood pressure level: normal blood pressure (n=39), stage 1 hypertension (n=65), and stage 2 hypertension (n=56). Measurements of body mass index (BMI), waist and hip circumference, glycated hemoglobin (HbA1c) level, lipid profile and blood pressure were taken.
Results: In the first cohort, latent carbohydrate metabolism disorders, defined by an HbA1c level ≥5.7%, were detected in 59.1% of women, of whom 20.5% had an HbA1c level ≥6.5%, meeting the criteria for latent diabetes. A decrease in high-density lipoprotein (HDL) levels was observed in 15%, and hypertriglyceridemia in 35%. In the cohort with exogenous-constitutional obesity, a significant deterioration in the lipid profile and an increase in metabolic disorders were found in the group of women with stage 2 hypertension compared to the group with normal blood pressure. A statistically significant negative correlation was found between waist circumference and HDL levels (r=0.37; p=0.035), emphasizing the pathogenetic role of visceral fat in the development of dyslipidemia and cardiometabolic risk.
Conclusions: Abdominal and exogenous-constitutional obesity in young women are associated with a high incidence of latent metabolic disorders, requiring timely comprehensive screening to assess the degree of obesity, blood pressure, and metabolic parameters to prevent the development of diabetes mellitus and cardiovascular complications.